The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.

Medtronic Plc announced a voluntary ... notifying global customers of its MiniMed 600 series or 700 series insulin pumps to ...

Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices ...

Insulin pump therapy ... A.L.P. has been a consultant for Medtronic MiniMed and has received a grant from the Medtronic/MiniMed Foundation. She has served as a consultant and/or speaker for ...

Medtronic's MiniMed 670G - the closest thing yet to ... system comprises a blood glucose sensor, the MiniMed 670G insulin pump and an infusion patch. Type 1 diabetes patients using the device ...

Medtronic's MiniMed 670G hybrid closed loop system ... to the body to measure glucose levels under the skin and an insulin pump strapped to the body. Attached to the pump is an infusion patch ...

Growth prospects remain bright. As type 1 and type 2 diabetes continue inflicting people, Medtronic's solutions such as MiniMed (insulin pump), InPen (real-time continuous glucose monitoring and ...

Hybrid closed-loop systems outperformed other types of subcutaneous insulin treatment for diabetes, but some systems were more efficient than others, according to results published in ...

Medtronic (NYSE: MDT ... In diabetes care, the MiniMed 780G insulin pump system uses AI algorithms to predict and adjust insulin delivery based on real-time blood sugar monitoring.

The various makes and models of pump available use different technological ... A.L.P. has been a consultant for Medtronic MiniMed and has received a grant from the Medtronic/MiniMed Foundation.